Bitcoin and Ether fell during Monday afternoon trading in Hong Kong, with XRP leading losses in the top 10 non-stablecoin cryptocurrencies by market capitalization....
Over the past decade, the rapid advancement of immunotherapies has been revolutionary in several cancers. However, pancreatic ductal adenocarcinoma, or PDAC, has been described...
The development of mRNA vaccines against COVID-19 has showcased the potential of RNA-based approaches, generating significant enthusiasm and investment in the field. RNA-based therapeutics...
EIT Health Catapult is on a mission to boost innovation in the rapidly-developing life sciences and healthtech markets, and has super success stories to...
Researchers worldwide are rapidly developing novel, ground-breaking applications for mRNA technology in the diagnosis and treatment of diseases, owing to their rapid development and...
Eroom’s Law (the backwards Moore) is the often cited, and arguably inaccurate, observation that drug discovery gets slower and more expensive over time. It’s...
BioNTech SE has completed construction at a German facility for making a key ingredient in its messenger-RNA vaccines, the sort of investment that pharma...
Biopharmaceutical New Technologies (BioNTech), the global immunotherapy company based in Mainz, Germany, is scheduled to ship its BioNTainer modular mRNA vaccine factory to...
